ArticleJournal of medical ethics2005
Informed consent should be obtained from patients to use products (skin substitutes) and dressings containing biological material.
Article in Journal of medical ethics, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers, 3 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
30 citing papers in PubMed, 3 syntheses or guidelines pooled it, 111 citations in OpenAlex.
- Skin grafting for venous leg ulcers.The Cochrane database of systematic reviews · 2013Pooled it
- Venous leg ulcers.BMJ clinical evidence · 2011Pooled it
- Venous leg ulcers.BMJ clinical evidence · 2008Pooled it
- Consenting for intraoperative use of animal- and human-derived products: a case of the blind leading the blind?Annals of the Royal College of Surgeons of England · 2026Article
- Jewish Perspectives on Porcine Xenotransplantation: Balancing Religious Ethics and Medical Necessity in Israel.Journal of religion and health · 2026Article
- Islamic reasoning and the use of prohibited medicines among Muslim patients: a qualitative study.International journal of clinical pharmacy · 2025Article
- Article
- The unseen animal behind medicine: exploring considerations of animal-derived medications and anaesthetics in today's landscape.BJA open · 2025Review
- Uninformed Origins: Should We Be Advising Parents on the Source of Medicines and Therapies?Health care analysis : HCA : journal of health philosophy and policy · 2023Article
- Factoring patients' beliefs and values into decisions around anticoagulation: a community-led multi-cycle quality improvement project.Future healthcare journal · 2023Article
- The muslim patient and medical treatments based on porcine ingredients.BMC medical ethics · 2023Article
- Are vegans being overlooked in our prescribing practices: An orthopaedic perspective from Bristol, United Kingdom.Journal of clinical orthopaedics and trauma · 2023Review
- Skin Bank Establishment in Treatment of Severe Burn Injuries: Overview and Experience with Skin Allografts at the Vienna Burn Center.Journal of clinical medicine · 2023Article
- The Social and Material Life of Antimicrobial Clay: Exploring Antimicrobial Resistance, Medicines' Materiality, and Medicines Optimization.Frontiers in sociology · 2020Article
- Ethics and Policy for Bioprinting.Methods in molecular biology (Clifton, N.J.) · 2020Article
- Using animal-derived constituents in anaesthesia and surgery: the case for disclosing to patients.BMC medical ethics · 2019Article
- Three Years' Experience of a Novel Biosynthetic Cellulose Dressing in Burns.Advances in wound care · 2019Article
- Skin bioprinting: the future of burn wound reconstruction?Burns & trauma · 2019Review
- Print Me an Organ? Ethical and Regulatory Issues Emerging from 3D Bioprinting in Medicine.Science and engineering ethics · 2018Article
- An audit of consent for allograft use in elective orthopaedic surgery.Annals of the Royal College of Surgeons of England · 2016Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 2 institutions in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundBiological products (tissue engineered skin, allograft and xenograft, and biological dressings) are widely used in the treatment of burns, chronic wounds, and other forms of acute injury. However, the religious and ethical issues, including consent, arising from their use have never been addressed in the medical literature.
aimsThis study was aimed to ascertain the views of religious leaders about the acceptability of biological products and to evaluate awareness among healthcare professionals about their constituents.
methodsThe religious groups that make up about 75% of the United Kingdom population were identified and a questionnaire on 11 biological products was sent to its leaders. Another questionnaire concerning 17 products (11 biological and 6 synthetic dressings) was sent to 100 healthcare professionals working in seven specialist units in the UK.
resultsAll religious leaders (100% response rate) replied, some after consultation with international bodies. Among them, 77% said that patients should be informed of the constituents of the biological products and consent obtained. Some leaders expressed concerns about particular products including the transmission of viral and prion diseases, cruelty to animals, and material derived from neonates. None of the healthcare professionals (73% response rate) surveyed knew the constituents of all the products correctly.
conclusionIgnoring religious sensitivities and neglecting consent in the usage of biological products could have very serious implications, including litigation. Hospitals and manufacturers should take immediate measures to enlighten healthcare professionals of the constituents of these products so that they can obtain informed consent from patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.